Facebook CEO Mark Zuckerberg and his wife Priscilla Chan's non-profit medical research organisation has announced it will be investing $50 million in its first class of 47 disease investigators in an endeavour to help cure all diseases in our children's lifetime.
The Chan Zuckerberg Biohub (CZ Biohub), which aims to create a "planet without disease", funded 47 scientists, technologists and engineers working at University of Stanford, University of California - San Francisco (UCSF) and University of Berkeley -- which includes nearly 50 per cent women and 15 per cent underrepresented minorities.
"We're investing $50 million in this first class of investigators. This programme will provide five years of funding to some of the most innovative researchers," Zuckerberg was quoted as saying in a Facebook post on Wednesday.
"This first group includes a Stanford data scientist working to analyze massive quantities of genomic data, a doctor from UCSF looking at how malaria spreads, an engineer from Berkeley who is designing tools to better understand human biology, including a miniature foldable microscope, and more," Zuckerberg added.
Each of the CZ Biohub researcher will receive a five-year appointment and up to $1.5 million in funding to conduct life science research in their respective areas of expertise.
"CZ Biohub investigators share our vision of a planet without disease," said Joseph DeRisi, co-president of CZ Biohub and Professor at UC San Francisco.
"CZ Biohub Investigators will challenge traditional thinking in pursuit of radical discoveries that will make even the most stubborn and deadly diseases treatable," DeRisi noted.
--IANS
rt/sm/dg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
